AW
FATE icon

Avion Wealth’s Fate Therapeutics FATE Stock Holding History

Avion Wealth’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2K Hold
858
– – ﹤0.01% 1037
2026
Q2 		$2K Buy
858
+233
+37% +$431 ﹤0.01% 1051
2026
Q1 		$0 Hold
625
– – ﹤0.01% 1350
2025
Q4 		$0 Hold
625
– – ﹤0.01% 1342
2025
Q3 		$0 Hold
625
– – ﹤0.01% 1299
2025
Q2 		$0 Buy
+625
New +$726 ﹤0.01% 1299
2023
Q4 		– Sell
-179
Closed – – 1156
2023
Q3 		$0 Buy
179
+83
+86% +$275 ﹤0.01% 922
2023
Q2 		$0 Buy
+96
New +$530 ﹤0.01% 813

Other funds holding FATE

Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Avion Wealth's FATE Position: Q3 2026 in Review

Avion Wealth held its Fate Therapeutics (FATE) position steady in Q3 2026 at 858 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1037.

Avion Wealth first reported a position in FATE in Q2 2023 and has held it in 8 quarters since. 55 funds tracked by Wall St. Rank hold FATE as of Q3 2026.

  • Avion Wealth held 858 shares of Fate Therapeutics worth $2K as of Q3 2026.
  • Avion Wealth left its Fate Therapeutics share count unchanged in Q3 2026.
  • Fate Therapeutics made up ﹤0.01% of Avion Wealth's portfolio in Q3 2026, its #1037 holding.
  • Avion Wealth first reported a position in Fate Therapeutics in Q2 2023 and has held it in 8 quarters since.
  • 55 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2026.

Based on Avion Wealth's 13F filing for Q3 2026, filed 4 Nov 2026.